Semnur Pharmaceuticals, Inc. Interest Expense Nonoperating
Semnur Pharmaceuticals, Inc. (SMNR) reported Interest Expense Nonoperating of $123.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $123.00K.
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $26.97K, a 26.62% increase year-over-year.
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2024-12-31 was $26.69K, a 50.70% increase year-over-year.
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for fiscal 2024 was $96.24K, a 160.75% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. interest expense nonoperating for fiscal 2023 was $36.91K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123.00K 10-Q · filed 2026-08-10 | $123.00K 10-Q · filed 2026-08-10 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $28.34K 10-Q · filed 2025-08-15 | $0.00 10-Q · filed 2026-08-10 | $55.32K 10-Q · filed 2025-08-15 | $53.67K derived: sum of 3 quarters · filed 2026-08-10 | $78.85K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $26.97K 10-Q · filed 2025-05-16 | $53.67K derived: sum of 2 quarters · filed 2025-05-16 | $78.85K derived: sum of 3 quarters · filed 2025-05-16 | $101.91K derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-12-31 | $26.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $51.88K derived: sum of 2 quarters · filed 2025-04-02 | $74.94K derived: sum of 3 quarters · filed 2025-08-15 | $96.24K 10-K · filed 2025-04-02 | ||
| 2024-09-30 | $25.19K 10-Q · filed 2024-11-19 | $48.25K derived: sum of 2 quarters · filed 2025-08-15 | $69.55K 10-Q · filed 2024-11-19 | $87.26K derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-06-30 | $23.06K 10-Q · filed 2025-08-15 | $44.36K 10-Q · filed 2025-08-15 | $62.07K derived: sum of 3 quarters · filed 2025-08-15 | $76.82K derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-03-31 | $21.30K 10-Q · filed 2025-05-16 | $39.02K derived: sum of 2 quarters · filed 2025-05-16 | $53.76K derived: sum of 3 quarters · filed 2025-05-16 | |||
| 2023-12-31 | $17.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $32.46K derived: sum of 2 quarters · filed 2025-04-02 | $36.91K 10-K · filed 2025-04-02 | |||
| 2023-09-30 | $14.75K 10-Q · filed 2024-11-19 | $19.20K 10-Q · filed 2024-11-19 |